Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

L. D. Lilien, G. Srinivasan, T. F. Yeh, R. S. Pildes

研究成果: 雜誌貢獻文章

4 引文 (Scopus)

摘要

The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

原文英語
頁(從 - 到)73-77
頁數5
期刊Pediatric Pharmacology
5
發行號1
出版狀態已發佈 - 一月 1 1985
對外發佈Yes

指紋

Patent Ductus Arteriosus
Premature Infants
Indomethacin
Glucose
Insulin
Therapeutics
Carbohydrate Metabolism
Intravenous Infusions
Birth Weight
Intravenous Administration
Gestational Age
Prostaglandins

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

引用此文

Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. / Lilien, L. D.; Srinivasan, G.; Yeh, T. F.; Pildes, R. S.

於: Pediatric Pharmacology, 卷 5, 編號 1, 01.01.1985, p. 73-77.

研究成果: 雜誌貢獻文章

@article{81c567ea0486481fbc195e32d2f683d9,
title = "Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus",
abstract = "The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.",
author = "Lilien, {L. D.} and G. Srinivasan and Yeh, {T. F.} and Pildes, {R. S.}",
year = "1985",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "73--77",
journal = "Pediatric Pharmacology",
issn = "0270-322X",
number = "1",

}

TY - JOUR

T1 - Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus

AU - Lilien, L. D.

AU - Srinivasan, G.

AU - Yeh, T. F.

AU - Pildes, R. S.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

AB - The effect of indomethacin on carbohydrate metabolism was studied in 6 premature infants with significant patent ductus arteriosus (mean ± S.D., birth weight 1,066 ± 244 gm, gestational age 30 ± 1.6 weeks). All infants were in a glucose steady state between 50 and 100 mg/dl over a 2-hour period before indomethacin administration. There was a significant fall in plasma glucose at 1, 6, 12, and 24 hours following intravenous indomethacin infusion. Since there was no significant change in insulin levels from the baseline, the mechanism of indomethacin-mediated lack of prostaglandin inhibition of insulin release was not substantiated. Based on this study, plasma glucose levels should be followed closely in the first 24 hours following intravenous indomethacin administration.

UR - http://www.scopus.com/inward/record.url?scp=0021944080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021944080&partnerID=8YFLogxK

M3 - Article

C2 - 3887313

AN - SCOPUS:0021944080

VL - 5

SP - 73

EP - 77

JO - Pediatric Pharmacology

JF - Pediatric Pharmacology

SN - 0270-322X

IS - 1

ER -